SEC registrant · CIK 0000892822

HEMAGEN DIAGNOSTICS INC

HEMAGEN DIAGNOSTICS INC (CIK 0000892822, EIN 04-2869857) reported revenue of $4.04 million ($4,042,094) for FY2012 (2011-10-01 to 2012-09-30) and net income of -$907,315 for FY2012 (2011-10-01 to 2012-09-30), as filed in its 10-K filed 2012-12-28 (accession 0001445866-12-001120).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends September 30).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0000892822
EIN04-2869857
SIC industry code2835 In Vitro & In Vivo Diagnostic Substances
State or country of incorporationDE
Fiscal year endSeptember 30
Entity typeoperating
Olympus entity IDorg_5awm0n5ph0d35ktym9w5jae58x
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$4,042,094FY20122011-10-01 to 2012-09-3010-K2012-12-280001445866-12-001120SalesRevenueNet
Net income-$907,315FY20122011-10-01 to 2012-09-3010-K2012-12-280001445866-12-001120NetIncomeLoss
Total assets$2,442,744FY2012as of 2012-09-3010-K2012-12-280001445866-12-001120Assets
Total liabilities$5,999,545FY2012as of 2012-09-3010-K2012-12-280001445866-12-001120Liabilities
Stockholders' equity-$3,556,801FY2012as of 2012-09-3010-K2012-12-280001445866-12-001120StockholdersEquity
Operating cash flow-$358,687FY20122011-10-01 to 2012-09-3010-K2012-12-280001445866-12-001120NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.06 per shareFY20122011-10-01 to 2012-09-3010-K2012-12-280001445866-12-001120EarningsPerShareDiluted
Shares outstanding15,500,281 sharesFY2012as of 2012-12-1310-K2012-12-280001445866-12-001120EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2003-2012, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20122011-10-01 to 2012-09-30$4,042,09410-K2012-12-280001445866-12-001120
RevenueFY20112010-10-01 to 2011-09-30$5,141,22610-K2012-12-280001445866-12-001120
Net incomeFY20122011-10-01 to 2012-09-30-$907,31510-K2012-12-280001445866-12-001120
Net incomeFY20112010-10-01 to 2011-09-30-$880,47610-K2012-12-280001445866-12-001120

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-K2012-12-282012-09-300001445866-12-001120hem10k930.htm
10-Q2012-08-142012-06-300001445866-12-000603hemagen10q.htm
10-Q2012-05-152012-03-310001445866-12-000352hemagen10q05092012.htm
10-Q2012-02-142011-12-310001445866-12-000060hemagen10q-02092012.htm
10-K2011-12-232011-09-300001445866-11-000164hem10k09302011.htm
10-Q/A2011-09-142011-06-300000823579-11-000446hem10q06302010.htm
10-Q2011-08-152011-06-300000823579-11-000254hem10q06302010.htm
10-Q2011-05-162011-03-310000892251-11-000050form10q033111.htm
10-Q2011-02-092010-12-310000892251-11-000017form10q123110.htm
10-K2010-12-232010-09-300001193125-10-287234d10k.htm
10-Q2010-08-162010-06-300000892251-10-000149form10q063010.htm
10-Q2010-05-142010-03-310000892251-10-000110form10q033110.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0000892822published by the sourcedata.sec.gov/submissions/CIK0000892822.json2026-10-21
Employer Identification Number (EIN) · US-EIN04-2869857published by the sourcedata.sec.gov/submissions/CIK0000892822.json2026-10-21

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0000892822.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0000892822.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000892822" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000892822/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000892822/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"892822"}

On SEC EDGAR

About this data